Cerus announced inclusion of pathogen reduction technology in ISBT recommendations for preparation of COVID-19 convalescent plasma
On Apr. 2, 2020, Cerus announced that the International Society of Blood Transfusion (ISBT) Working Party on Global…
Biotechnology | COVID-19 | FDA | Therapeutics
Incyte initiated phase 3 clinical trial of Ruxolitinib (Jakafi) as treatment for patients with COVID-19 cytokine storm
On Apr. 2, 2020, Incyte announced it was working with the U.S. Food and Drug Administration (FDA) to…
Emergent BioSolutions partnered with U.S. Government to expedite development of plasma-derived therapy for COVID-19
On Apr. 2, 2020, Emergent BioSolutions announced it had entered into a formal partnership with the U.S. government…
Paratek Pharma announced BARDA funding for onshoring the manufacturing supply for NUZYRA (omadacycline)
On Apr. 1, 2020, Innovation Pharma announced BARDA had initiated funding to support the onshoring of Paratek manufacturing…
Early study of COVID-19 patients showed high mortality rate
On Apr. 1, 2020, a University of Washington Medicine led study of 24 of the most critically ill…
Kleo Pharmaceuticals announced research collaboration with Green Cross LabCell to develop COVID-19-targeting allogeneic NK Cell combination therapy
On Mar. 31, 2020, Kleo Pharmaceuticals announced it had entered into a research collaboration with South Korea -based…
Mayo Clinic in Florida expanded specimen testing and processing capabilities for COVID-19
On Mar. 31, 2020, Mayo Clinic in Florida announced it had significantly ramped up efforts to process and…
BD, BioMedomics announced launch of rapid serology test to detect exposure to COVID-19
On Mar. 31, 2020, BD (Becton, Dickinson and Company) and BioMedomics announced the release of a new point-of-care…
Emergent BioSolutions signed agreement with Novavax to manufacture NanoFlu
On Mar. 31, 2020, Emergent BioSolutions announced an agreement with Novavax whereby Emergent provided molecule-to-market contract development and…
University of Minnesota researchers orchestrated state’s fastest on-site testing for COVID-19
On Mar. 31, 2020, the University of Minnesota announced that the Medical School transformed two research buildings to…
Roswell Park’s Dr. Pawel Kalinski lead $145 million NCI-funded immunotherapy effort
On Mar. 31, 2020, a team led by Pawel Kalinski, MD, PhD, of Roswell Park Comprehensive Cancer Center…
Luminex received BARDA contract to support development of second, rapid SARS-CoV-2 test
On Mar. 31, 2020, Luminex announced it had received $642,450 in funding from the Biomedical Advanced Research and…
Fujifilm announced start of phase III clinical trial of influenza antiviral drug ‘Avigan Tablet’ on COVID-19 patients
On Mar. 31, 2020, FUJIFILM announced initiation of a phase III clinical trial to evaluate the safety and…
Philips to fulfill contract with the HHS for the delivery of 10,000 Trilogy Universal units with accelerated delivery
On Mar. 31, 2020, Philips announced that it was fully committed to fulfill the contract with the U.S….
Cue Health awarded $13 million for rapid, portable, point-of-Care COVID-19 test by BARDA
On Mar. 31, 2020, Cue Health announced that is had been awarded up to $30 million in base…
COVID-19 Therapeutics Accelerator awarded $20 million in initial grants to fund clinical trials
On Mar. 30, 2020, the partners in the COVID-19 Therapeutics Accelerator announced grants of $20 million to three…
TGen, a genomic first responder, ramped up testing against COVID-19 coronavirus
On Mar. 30, 2020, the Translational Genomics Research Institute (TGen) announced that it had joined the world-wide effort…
La Jolla Institute for Immunology hosted coronavirus immunotherapy clearinghouse
On Mar. 30, 2020, the La Jolla Institute for Immunology (LJI) announced it had been awarded a $1.73…
Altimmune and the University of Alabama at Birmingham to collaborate on development of single-dose, intranasal COVID-19 vaccine
On Mar. 30, 2020, Altimmune announced that it was launching a collaboration with the University of Alabama at…
Biotechnology | COVID-19 | FDA | Therapeutics
FDA issued EUA to allow hydroxychloroquine sulfate and chloroquine phosphate products from Strategic National Stockpile to be distributed
On Mar. 28, 2020, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to…
Medtronic launched new solutions to help monitor patients for COVID-19
On Mar. 27, 2020, Medtronic announced its Medtronic Care Management Services (MCMS) business had launched two new solutions…
Biotechnology | COVID-19 | Diagnostics | FDA
CIRM approved $5 Million in emergency funding for COVID-19 research
On Mar. 27, 2020, in response to the crisis caused by the COVID-19 virus in California and around…
Humanigen submitted phase III protocol synopsis to FDA for lenzilumab for Coronavirus treatment
On Mar. 27, 2020, Humanigen announced that the company had submitted an initial protocol synopsis to U.S. Food…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Vaccine
Emory University new site in NIH-sponsored coronavirus vaccine study
On Mar. 27, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced participation in a clinical trial testing…
Amyris launched hand sanitizer and receives initial positive result for vaccine adjuvant
On Mar. 26, 2020, Amyris announced that it had completed initial testing of a leading vaccine adjuvant. In…
UC Health launched clinical trials to assess antiviral drug for COVID-19
On Mar. 26, 2020, physician-scientists at four University of California Health medical centers — UC San Diego Health,…
Broad Institute’s CLIA-certified testing center began processing COVID-19 patient samples
On Mar. 26, 2020, working in partnership with the Commonwealth of Massachusetts, Massachusetts State Public Health Laboratory, and…
Henry Schein announced availability of COVID-19 point-of-care antibody rapid test
On Mar. 26, 2020, Henry Schein announced the availability of an antibody rapid blood test, known as Standard…
Thermo Fisher Scientific received CE Mark for its diagnostic test todDetect COVID-19
On Mar. 26, 2020, Thermo Fisher Scientific announced it had received the CE mark in the European Union…
Eight US Manufacturers Selected to Make NASA COVID-19 Ventilator
On Mar. 25, 2020, NASA’s Jet Propulsion Laboratory (JPL) in Southern California announced that after receiving more than…